Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei

British Journal of Surgery

Volumn 92, Issue 2, 2005, Pages 153-158

  Bryant, J ^a   Clegg, A J ^a   Sidhu, M K ^a   Brodin, H ^a   Royle, P ^a   Davidson, P ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ABDOMINAL SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; DATA ANALYSIS; DATA BASE; DISEASE COURSE; ECONOMIC ASPECT; FOLLOW UP; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; MEDICAL LITERATURE; METHODOLOGY; MODEL; MONTE CARLO METHOD; MORBIDITY; MORTALITY; PERITONEUM PSEUDOMYXOMA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; STANDARD; SUGARBAKER OPERATION; SURGICAL PATIENT; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

COSTS AND COST ANALYSIS; HUMANS; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PSEUDOMYXOMA PERITONEI; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME;

EID: 13944273755     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.4862     Document Type: Review

References (17)

1. Sugarbaker PH, Ronnett BM, Archer A, Averbach AM, Bland R, Chang D et al. Pseudomyxoma peritonei syndrome. Adv Surg 1996; 30: 233-280.
2. Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg 1998; 85: 1332-1339.
3. Wirtzfeld DA, Rodriguez-Bigas M, Weber T, Petrelli NJ. Disseminated peritoneal adenomucinosis: a critical review. Ann Surg Oncol 1999; 6: 797-801.
4. Sugarbaker PH. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg 1994; 219: 109-111.
5. Sherer DM, Abulafia O, Eliakim R. Pseudomyxoma peritonei: a review of the current literature. Gynecol Obstet Invest 2001; 51: 73-80.
6. Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favourable prognosis than patients with peritoneal mucinosis carcinomatosis. Cancer 2001; 92: 85-91.
7. Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg 2000; 87: 1414-1418.
8. Bryant J, Clegg AJ, Sidhu MK, Brodin H, Royle P, Davidson P. Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei. Health Technol Assess 2004; 8(7).
9. NHS Centre for Reviews and Dissemination. Undertaking Systematic Reviews of Research on Effectiveness: CRD's Guidance for those Carrying Out or Commissioning Reviews. CRD Report 4 (2nd edn). York: NHS Centre for Reviews and Dissemination; 2001.
10. Briggs AH. Handling uncertainty in cost-effectiveness models. Pharmacoeconomics 2000; 17: 479-500.
11. Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 2001; 27: 239-243.
12. van Ruth S, Acherman YIZ, van de Vijver MJ, Hart AAM, Verwaal VJ, Zoetmulder FAN. Pseudomyxoma peritonei: a review of 62 cases. Eur J Surg Oncol 2003; 29: 682-688.
13. Smith JW, Kemeny N, Caldwell C, Banner P, Sigurdson E, Huvos A. Pseudomyxoma peritonei of appendiceal origin. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1992; 70: 396-401.
14. Sugarbaker PH, Zhu BW, Sese GB, Shmookler B. Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 1993; 36: 323-329.
15. Lilford R, Braunholtz D, Harris J, Gill T. Trials in surgery. Br J Surg 2004; 91: 6-16.
16. National Institute for Clinical Excellence website. Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique). http://www.nice.org.uk/cms/ip/ipcat.aspx?o=56772 [28 April 2004].
17. Cancer service website. http://www.advisorybodiesdoh. gov.uk/nscag [20 April 2004].